Log in

Relevant bibliographies by topics / Radiation-induced lymphopenia / Journal articles

To see the other types of publications on this topic, follow the link: Radiation-induced lymphopenia.

Journal articles on the topic 'Radiation-induced lymphopenia'

Author: Grafiati

Published: 26 October 2024

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Radiation-induced lymphopenia.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Wang, Xin, Peiliang Wang, Zongxing Zhao, Qingfeng Mao, Jinming Yu, and Minghuan Li. "A review of radiation-induced lymphopenia in patients with esophageal cancer: an immunological perspective for radiotherapy." Therapeutic Advances in Medical Oncology 12 (January 2020): 175883592092682. http://dx.doi.org/10.1177/1758835920926822.

Full text

Abstract:

Radiotherapy is a frequently utilized therapeutic modality in the treatment of esophageal cancer (EC). Even though extensive studies are carried out in radiotherapy for EC, the design of the clinical target volume and the radiation dose is not satisfactorily uniform. Radiotherapy acts as a double-edged sword on the immune system; it has both an immunostimulatory effect and an immunosuppressive effect. Radiation-induced lymphopenia and its potential association with tumor control and survival outcomes remain to be understood. The advent of immunotherapy has renewed the focus on preserving a poo

APA, Harvard, Vancouver, ISO, and other styles

2

Ballal, Suhas, Shruti Chandak, Karan Ram Lal Gupta, and Geetika M. Patel. "A systematic review of the management and implications of radiation-induced lymphopenia and the predictive rate of radiomic-based approaches in lung cancer." Multidisciplinary Reviews 6 (January 29, 2024): 2023ss008. http://dx.doi.org/10.31893/multirev.2023ss008.

Full text

Abstract:

Radiation therapy remains a crucial treatment option for lung cancer, but radiation-induced lymphopenia can impact treatment results and patient well-being. Radiomics-based techniques have made it easier to predict therapy response and patient outcomes by extracting and analyzing quantitative imaging characteristics. This review examines radiation-induced lymphopenia management and its consequences while evaluating the predictive capabilities of radiomics-based approaches in the lung cancer context. A systematic review was undertaken using Scinapse, Scholar and PubMed, with 1247 papers chosen

APA, Harvard, Vancouver, ISO, and other styles

3

Sashidharan, Srijith, Azadeh Abravan, Peter Sitch, Cy Howells, Ed Smith, and Shermaine Pan. "Radiation-induced lymphopenia with proton beam therapy (PBT)." Clinical Oncology 34 (September 2022): e2-e3. http://dx.doi.org/10.1016/j.clon.2022.08.009.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Sengupta, Sadhak, Jaclyn Marrinan, Caroline Frishman, and Prakash Sampath. "Impact of Temozolomide on Immune Response during Malignant Glioma Chemotherapy." Clinical and Developmental Immunology 2012 (2012): 1–7. http://dx.doi.org/10.1155/2012/831090.

Full text

Abstract:

Malignant glioma, or glioblastoma, is the most common and lethal form of brain tumor with a median survival time of 15 months. The established therapeutic regimen includes a tripartite therapy of surgical resection followed by radiation and temozolomide (TMZ) chemotherapy, concurrently with radiation and then as an adjuvant. TMZ, a DNA alkylating agent, is the most successful antiglioma drug and has added several months to the life expectancy of malignant glioma patients. However, TMZ is also responsible for inducing lymphopenia and myelosuppression in malignant glioma patients undergoing chem

APA, Harvard, Vancouver, ISO, and other styles

5

Yu, Hao, Fang Chen, Li Yang, Jian-Yue Jin, and Feng-Ming Spring Kong. "Potential determinants of radiation-induced lymphocyte decrease and lymphopenia in breast cancer patients by machine learning approaches." Journal of Clinical Oncology 39, no. 15_suppl (2021): e12567-e12567. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.e12567.

Full text

Abstract:

e12567 Background: Radiation-induced lymphopenia accompanied with radiation therapy is associated with inferior clinical outcomes in a wide variety of solid malignancies. This study aimed to examine the potential determines of radiation-induced lymphocyte decrease and radiation-induced lymphopenia in breast cancer patients who underwent radiotherapy. Methods: Patients with breast cancer treated who underwent radiotherapy were enrolled in University of Hong Kong-Shenzhen Hospital (our cohort). Circulating lymphocyte levels were evaluated within 7 days prior to and end of radiation therapy. Feat

APA, Harvard, Vancouver, ISO, and other styles

6

Jin, Jian-Yue, Todd Mereniuk, Anirudh Yalamanchali, et al. "A framework for modeling radiation induced lymphopenia in radiotherapy." Radiotherapy and Oncology 144 (March 2020): 105–13. http://dx.doi.org/10.1016/j.radonc.2019.11.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Gupta, Priti, Min Wang, and Steven Lin. "Abstract 1118: Mitigating radiation-induced lymphopenia using interleukin-15: Preclinical rationale for clinical translation." Cancer Research 84, no. 6_Supplement (2024): 1118. http://dx.doi.org/10.1158/1538-7445.am2024-1118.

Full text

Abstract:

Abstract Background: Radiation therapy is a common treatment for cancer patients, with nearly 50% of them undergoing this procedure. While radiation is effective at targeting tumor cells, it also has the unintended consequence of killing lymphocytes, which are among the most sensitive cells to radiation within the erythroid, myeloid, and lymphoid lineages. This phenomenon is known as radiation-induced lymphopenia (RIL) and is considered a negative prognostic factor in various malignant solid tumors. It occurs severely in over 40% of solid tumor patients who receive radiotherapy. Some previous

APA, Harvard, Vancouver, ISO, and other styles

8

Zhao, Qianqian, Tingting Li, Shisuo Du, Jian He, and Zhaochong Zeng. "Shortened Radiation Time Promotes Recovery From Radiation-induced Lymphopenia in Early-Stage Non-small Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy." Technology in Cancer Research & Treatment 21 (January 2022): 153303382211122. http://dx.doi.org/10.1177/15330338221112287.

Full text

Abstract:

Background: To evaluate the potential impact of radiation time on radiation-induced lymphopenia (RIL) and subsequently recovery after stereotactic body radiation therapy (SBRT) and to examine the associations between radiation time and with patient outcomes in early-stage non-small cell lung cancer (NSCLC). Methods: Clinical and laboratory records of subjects consisted of 115 patients who had received SBRT for early-stage NSCLC. Clinical and laboratory records were retrospective reviewed to assess the changes in total lymphocyte counts (TLCs) following SBRT. Associations of TLCs kinetics with

APA, Harvard, Vancouver, ISO, and other styles

9

Ishida, Naoko, Yukinori Matsuo, Junki Fukuda, et al. "Radiation-Induced Lymphopenia and Its Impact on Survival in Patients with Brain Metastasis." Current Oncology 31, no. 8 (2024): 4559–67. http://dx.doi.org/10.3390/curroncol31080340.

Full text

Abstract:

Background: Differences in radiation-induced lymphopenia and prognosis between methods of radiotherapy (RT) for brain metastases remain unclear. Methods: In this retrospective analysis of patients who underwent whole-brain radiotherapy (WBRT) or stereotactic radiosurgery/radiotherapy (SRS/SRT) for brain metastases, baseline total lymphocyte count (TLC) data were obtained within 2 weeks before RT initiation. Follow-up TLC data were evaluated at 0–2, 2–4, and 4–8 weeks after RT completion. Persistent lymphopenia was defined as <800/μL at any time point. Results: Overall, 138 RT courses in 128

APA, Harvard, Vancouver, ISO, and other styles

10

Alsamari, F., M. Aldehaim, A. Aldakheel, et al. "The Prognostic Significance of Radiation-Induced Lymphopenia in Nasopharyngeal Carcinoma." International Journal of Radiation Oncology*Biology*Physics 120, no. 2 (2024): e730. http://dx.doi.org/10.1016/j.ijrobp.2024.07.1605.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Al-Hamami, Sarah F. A., Samuel Kurucz, Vladimír Vondráček, Vladimír Pekar, and Jiří Kubeš. "607: Radiation-induced lymphopenia in proton therapy for prostate cancer." Radiotherapy and Oncology 194 (May 2024): S5160—S5162. http://dx.doi.org/10.1016/s0167-8140(24)01179-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Gomis Selles, E., Ó. Muñoz Muñoz, B. D. Delgado León, P. Cabrera Roldán, A. M. Burgueño Caballero, and J. L. López Guerra. "PO-1569 Radiation-induced lymphopenia in pediatric high-risk neuroblastoma." Radiotherapy and Oncology 182 (May 2023): S1273—S1274. http://dx.doi.org/10.1016/s0167-8140(23)66484-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Ellsworth, S., G. Rebesco, K. Fife, and S. Grossman. "Radiation-Induced Lymphopenia and Virologic Outcomes in HIV-Positive Patients Undergoing Radiation for Cancer." International Journal of Radiation Oncology*Biology*Physics 96, no. 2 (2016): E526—E527. http://dx.doi.org/10.1016/j.ijrobp.2016.06.1948.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Ni, Wenjie, Xiunan Wang, Qin Wang, Yongqing Ge, and Xiaofeng Mu. "Radiation-Induced Lymphopenia Prognosis and Risk Factors in Postmastectomy Radiotherapy Patients." Cancer Management and Research Volume 17 (May 2025): 1047–58. https://doi.org/10.2147/cmar.s522807.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Kuncman, Ł., K. Stawiski, M. Bilski, J. Nowak-Potemska, M. Bilewicz, and J. Fijuth. "Radiation Induced Lymphopenia Depends on Lymph Node Irradiation in Prostate Cancer Radiotherapy." International Journal of Radiation Oncology*Biology*Physics 120, no. 2 (2024): e549-e550. http://dx.doi.org/10.1016/j.ijrobp.2024.07.1216.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Ellsworth, S. G., T. Mereniuk, H. Zhang, et al. "Kinetics and Dosimetric Predictors of Acute Radiation-Induced Lymphopenia in Pancreatic Cancer." International Journal of Radiation Oncology*Biology*Physics 102, no. 3 (2018): e71. http://dx.doi.org/10.1016/j.ijrobp.2018.07.414.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Ellsworth, Susannah G., Todd Mereniuk, Robert F. Hobbs, et al. "Kinetics and dosimetric predictors of acute radiation-induced lymphopenia in pancreatic cancer." Journal of Clinical Oncology 36, no. 4_suppl (2018): 300. http://dx.doi.org/10.1200/jco.2018.36.4_suppl.300.

Full text

Abstract:

300 Background: Radiation (RT) induced lymphopenia (RIL) is an adverse prognostic factor in pancreatic cancer (PC) and is likely due to the irradiation of lymphocytes in the RT field. The goal of this study was to identify dosimetric predictors for high rates of absolute lymphocyte count (ALC) loss during RT for PC. Methods: This was a retrospective study of 34 PC patients in an institutional database who had received concurrent 5-FU or gemcitabine-based chemoradiation (50-54 Gy) and had ≥ 3 ALCs measured during RT. Baseline ALC was normal (>1000 cells/uL) in 28/34 (82%) and grade 3-4 RIL o

APA, Harvard, Vancouver, ISO, and other styles

18

Mohanty, S., A. Singh, U. Velu, K. Sharan, N. P. Jayashree, and S. Lewis Salins. "130P Radiation induced lymphopenia (RAILs on time saves nine): In carcinoma esophagus." Annals of Oncology 33 (November 2022): S1482—S1483. http://dx.doi.org/10.1016/j.annonc.2022.10.166.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Balmanoukian, Ani Sarkis, Xiaobu Ye, Joseph M. Herman, Dan Laheru, and Stuart A. Grossman. "Effect of treatment-related lymphopenia on survival in newly diagnosed patients with resected adenocarcinoma of the pancreas." Journal of Clinical Oncology 30, no. 4_suppl (2012): 270. http://dx.doi.org/10.1200/jco.2012.30.4_suppl.270.

Full text

Abstract:

270 Background: Severe treatment-related lymphopenia is associated with shorter survival in patients with high grade gliomas. This study was performed to determine if patients with resected pancreatic adenocarcinoma treated with post-operative radiation and chemotherapy develop significant lymphopenia and if this affects overall survival. Methods: Patients selected for this retrospective analysis underwent pancreatic cancer resection between 1997 and 2008, and received post-operative radiation with gemcitabine or 5-FU based chemotherapy at Johns Hopkins Hospital. Serial lymphocyte counts were

APA, Harvard, Vancouver, ISO, and other styles

20

Kim, Daniel W., Grace Lee, Theodore S. Hong, et al. "Prognostic impact of chemoradiation-related lymphopenia in patients with gastric and gastroesophageal cancer." Journal of Clinical Oncology 39, no. 3_suppl (2021): 249. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.249.

Full text

Abstract:

249 Background: Limited data exists on how chemoradiation (CRT)-induced lymphopenia affects survival outcomes in patients with gastric and gastroesophageal junction (GEJ) cancer. We evaluated the association between severe lymphopenia and its association with survival in gastric and GEJ cancer patients treated with CRT. We hypothesized that severe lymphopenia would be a poor prognostic factor. Methods: We performed a retrospective analysis of 154 patients with stage 1-3 gastric or GEJ cancer who underwent CRT at our institution. Patients underwent photon-based radiation therapy (RT) with a med

APA, Harvard, Vancouver, ISO, and other styles

21

McLaughlin, Mark F., Morshed Alam, Lynnette Smith, Jeffrey Ryckman, Chi Lin, and Michael J. Baine. "Stereotactic body radiation therapy mitigates radiation induced lymphopenia in early stage non-small cell lung cancer." PLOS ONE 15, no. 11 (2020): e0241505. http://dx.doi.org/10.1371/journal.pone.0241505.

Full text

Abstract:

Introduction Radiation-induced lymphopenia (RIL) occurs during treatment with conventional radiation in multiple organ sites. Development of RIL portends poor prognosis. Stereotactic body radiation therapy (SBRT) spares RIL in pancreatic cancer, but has not been examined in other sites commonly treated with SBRT. This work examines if SBRT similarly spares RIL in patients with non-small cell lung cancer (NSCLC). Materials and methods Retrospective analysis was done at a single institution on 40 distinct cases of SBRT for early stage NSCLC from 2006–2017. Incidentally collected lymphocyte count

APA, Harvard, Vancouver, ISO, and other styles

22

Antunac, Katarina, Petar Suton, and Sara Bilić-Knežević. "Prognostic significance of radiation induced lymphopenia in patients with high risk prostate cancer." Libri Oncologici Croatian Journal of Oncology 46, no. 2-3 (2019): 55–59. http://dx.doi.org/10.20471/lo.2018.46.02-03.09.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Pan, S., P. Sitch, S. Gaito, et al. "PD-0076 Predictive factors of severe radiation-induced lymphopenia in proton-treated patients." Radiotherapy and Oncology 170 (May 2022): S51—S53. http://dx.doi.org/10.1016/s0167-8140(22)02746-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Mohanty, Sheel, Priyanka Augustine, Umesh Velu, et al. "CLO22-069: Radiation Induced Lymphopenia (RAILs on Time Saves Nine!) In Carcinoma Esophagus!" Journal of the National Comprehensive Cancer Network 20, no. 3.5 (2022): CLO22–069. http://dx.doi.org/10.6004/jnccn.2021.7233.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Kanehira, Takahiro, Hiroshi Taguchi, Jun Sakakibara-Konishi, et al. "1081: Comparing predictors of radiation-induced lymphopenia in various timeframes in NSCLC radiotherapy." Radiotherapy and Oncology 194 (May 2024): S5012—S5015. http://dx.doi.org/10.1016/s0167-8140(24)01550-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Chan, Landon L., Vanessa T. Y. Yeung, Frankie Mo, et al. "336: Radiation-induced lymphopenia predicts poor survival in HCC patients treated with radiotherapy." Radiotherapy and Oncology 194 (May 2024): S2133—S2137. http://dx.doi.org/10.1016/s0167-8140(24)00989-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Monti, Serena, Giuseppe Palma, Radhe Mohan, Ting Xu, Zhongxing Liao, and Laura Cella. "950: Prediction of radiation induced lymphopenia during chemoradiation therapy for lung cancer patients." Radiotherapy and Oncology 194 (May 2024): S5006—S5008. http://dx.doi.org/10.1016/s0167-8140(24)01449-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Campos, C. Terrones, B. Ledergerber, I. Vogelius, M. Helleberg, L. Specht, and J. Lundgren. "OC-0278 Radiation-induced lymphopenia: Fractionation effect and association with infections and mortality." Radiotherapy and Oncology 133 (April 2019): S137—S138. http://dx.doi.org/10.1016/s0167-8140(19)30698-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Ellsworth, S. G., H. Zhang, T. Mereniuk, et al. "Factors Affecting Kinetics of Acute Radiation-Induced Lymphopenia in Patients with Gastrointestinal Cancer." International Journal of Radiation Oncology*Biology*Physics 102, no. 3 (2018): e162-e163. http://dx.doi.org/10.1016/j.ijrobp.2018.07.623.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

MIRESTEAN, Camil Ciprian, Roxana Irina IANCU, and Dragos Teodor IANCU. "Immunotherapy and radiotherapy – a future partnership Focus on radiation induced lymphopenia (RIL) implications." Bratislava Medical Journal 124, no. 01 (2022): 70–73. http://dx.doi.org/10.4149/bll_2023_011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Sun, G., S. Wang, Y. Song, et al. "Radiation-Induced Lymphopenia is Associated with Radiation Fractionation and Predicts Poorer Prognosis in Patients with Breast Cancer." International Journal of Radiation Oncology*Biology*Physics 105, no. 1 (2019): E46. http://dx.doi.org/10.1016/j.ijrobp.2019.06.2369.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Low, Soon Khai, Samih Z. Thalji, Mohammed Aldakkak, et al. "Impact of neoadjuvant radiation therapy modalities on post-surgical lymphopenia in operable pancreatic cancer." Journal of Clinical Oncology 43, no. 4_suppl (2025): 710. https://doi.org/10.1200/jco.2025.43.4_suppl.710.

Full text

Abstract:

710 Background: Recent advances in therapeutic vaccines show promise for KRAS -mutated pancreatic cancer (PC), with ongoing clinical trials exploring their potential further. Lymphocytes are essential in generating vaccine-induced immune response. Patients who develop lymphopenia following neoadjuvant radiation therapy (RT) are frequently excluded from these vaccine trials. We aimed to assess how different modalities of neoadjuvant RT impact the severity and incidence of lymphopenia. Methods: We identified patients with PC who received neoadjuvant therapy including RT followed by surgery at ou

APA, Harvard, Vancouver, ISO, and other styles

33

Chen, Fang, Hao Yu, Hong Zhang, et al. "Risk factors for radiation induced lymphopenia in patients with breast cancer receiving adjuvant radiotherapy." Annals of Translational Medicine 9, no. 16 (2021): 1288. http://dx.doi.org/10.21037/atm-21-2150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Pike, Luke R. G., and Jonathan D. Schoenfeld. "Radiation-induced lymphopenia may negatively affect outcomes in patients receiving PD-1 directed immunotherapy." Therapeutic Radiology and Oncology 3 (December 2019): 37. http://dx.doi.org/10.21037/tro.2019.10.01.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Damen, Pim J. J., Max Peters, Brian Hobbs, et al. "923: Defining the optimal radiation-induced lymphopenia metric to discern survival in esophageal cancer." Radiotherapy and Oncology 194 (May 2024): S2176—S2178. http://dx.doi.org/10.1016/s0167-8140(24)01428-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Spina, C. S., B. Wothuis, C. Elliston, F. Baez, and T. J. C. Wang. "Chemoradiation-Induced Lymphopenia in Glioblastoma Patients and the Influence of Total Radiation Exposure Time." International Journal of Radiation Oncology*Biology*Physics 99, no. 2 (2017): E110—E111. http://dx.doi.org/10.1016/j.ijrobp.2017.06.858.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Bendavid, Jerome, Roger Sun, Pierre Blanchard, et al. "Radiation induced lymphopenia in unilateral versus bilateral radiochemotherapy in treatment of head and neck cancer: A retrospective case-control study." Journal of Clinical Oncology 41, no. 16_suppl (2023): e18065-e18065. http://dx.doi.org/10.1200/jco.2023.41.16_suppl.e18065.

Full text

Abstract:

e18065 Background: Grade 3+ radiation-induced lymphopenia is a frequent biological complication of external beam radiotherapy (RT) in the management of head and neck cancers, likely due to the large irradiated cervical volume. This complication has been shown to be a significant prognostic factor for mortality. The aim of this study is to evaluate the difference in lymphopenia and prognosis between unilateral and bilateral prophylactic lymph node irradiation in head and neck cancers. Methods: This is a retrospective, single center case – control study in patients who received unilateral or bil

APA, Harvard, Vancouver, ISO, and other styles

38

Sampson, J. H., K. D. Aldape, M. R. Gilbert, et al. "Temozolomide as a vaccine adjuvant in GBM." Journal of Clinical Oncology 25, no. 18_suppl (2007): 2020. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.2020.

Full text

Abstract:

2020 Background: Cytotoxic chemotherapy that induces lymphopenia is predicted to ablate the benefits of active antitumor immunization. Temozolomide (TMZ) is an effective chemotherapeutic for patients with glioblastoma multiforme (GBM), but it induces significant lymphopenia. Methods: In a Phase II trial, patients with newly-diagnosed, completely resected GBM are vaccinated with an EGFRvIII-specific peptide q2 weeks X 3 after radiation (XRT)(∼60Gy) and TMZ (75mg/m2/d) and then monthly with 5 day TMZ cycles (200mg/m2/d). Results: TMZ induces transient, Grade 3 lymphopenia (< 500 cells/uL) in

APA, Harvard, Vancouver, ISO, and other styles

39

Chen, F., H. Yu, Y. Nong, et al. "Risk Factors for Radiation Induced Lymphopenia in Patients With Breast Cancer: Does Radiotherapy Technique Matter?" International Journal of Radiation Oncology*Biology*Physics 111, no. 3 (2021): e204-e205. http://dx.doi.org/10.1016/j.ijrobp.2021.07.727.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Monti, Serena, Ting Xu, Zhongxing Liao, Radhe Mohan, Laura Cella, and Giuseppe Palma. "On the interplay between dosiomics and genomics in radiation-induced lymphopenia of lung cancer patients." Radiotherapy and Oncology 167 (February 2022): 219–25. http://dx.doi.org/10.1016/j.radonc.2021.12.038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Monti, S., L. Cella, T. Xu, R. Mohan, Z. Liao, and G. Palma. "OC-0637 Thoracic dose patterns associated with radiation induced lymphopenia in patients treated for NSCLC." Radiotherapy and Oncology 161 (August 2021): S502—S503. http://dx.doi.org/10.1016/s0167-8140(21)06993-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Ishida, Naoko, Yukinori Matsuo, Aritoshi Ri, et al. "744: Radiation-induced lymphopenia and its impact on survival in patients treated with brain radiotherapy." Radiotherapy and Oncology 194 (May 2024): S782—S784. http://dx.doi.org/10.1016/s0167-8140(24)01287-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Zhao, X., H. Fang, H. Jing, et al. "Radiation-Induced Lymphopenia in Patients with Breast Cancer after Mastectomy: Results from Chinese POTENTIAL Trial." International Journal of Radiation Oncology*Biology*Physics 114, no. 3 (2022): e39. http://dx.doi.org/10.1016/j.ijrobp.2022.07.760.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Sun, Joseph C., Joshua N. Beilke, Natalie A. Bezman, and Lewis L. Lanier. "Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection." Journal of Experimental Medicine 208, no. 2 (2011): 357–68. http://dx.doi.org/10.1084/jem.20100479.

Full text

Abstract:

Cells of the immune system undergo homeostatic proliferation during times of lymphopenia induced by certain viral infections or caused by chemotherapy and radiation treatment. Natural killer (NK) cells are no exception and can rapidly expand in number when placed into an environment devoid of these cells. We explored the lifespan and function of mouse NK cells that have undergone homeostatic proliferation in various settings of immunodeficiency. Adoptive transfer of mature NK cells into lymphopenic mice resulted in the generation of a long-lived population of NK cells. These homeostasis-driven

APA, Harvard, Vancouver, ISO, and other styles

45

Ghosh, Subhajit, Ran Yan, Sukrutha Thotala, et al. "EXTH-14. A NOVEL LONG-ACTING INTERLEUKIN-7 AGONIST, NT-I7, INCREASES CYTOTOXIC CD8 CELLS AND ENHANCES SURVIVAL IN MOUSE GLIOMA MODELS." Neuro-Oncology 22, Supplement_2 (2020): ii89. http://dx.doi.org/10.1093/neuonc/noaa215.368.

Full text

Abstract:

Abstract BACKGROUND Patients with glioblastoma (GBM) are treated with radiation (RT) and temozolomide (TMZ). These treatments can cause prolonged severe lymphopenia, which is associated with shorter survival. NT-I7 (efineptakin alfa) is a long-acting recombinant human IL-7 that supports the proliferation and survival CD4+ and CD8+ cells in both human and mice. We tested whether NT-I7 would protect T cells from treatment-induced lymphopenia and improve survival. METHODS C57BL/6 mice bearing intracranial tumors (GL261 or CT2A) were treated with RT (1.8 Gy/day x 5 days), TMZ (33 mg/kg/day x 5 day

APA, Harvard, Vancouver, ISO, and other styles

46

Venkatesulu, Bhanu Prasad, Supriya Mallick, Steven H. Lin, and Sunil Krishnan. "A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors." Critical Reviews in Oncology/Hematology 123 (March 2018): 42–51. http://dx.doi.org/10.1016/j.critrevonc.2018.01.003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

van Rossum, P. S. N., B. Stam, C. Juan-Cruz, M. M. G. Rossi, J. Belderbos, and J. J. Sonke. "Severe Radiation-Induced Lymphopenia during Concurrent Chemoradiotherapy for Lung Cancer: External Validation of Two Prediction Models." International Journal of Radiation Oncology*Biology*Physics 114, no. 3 (2022): e394. http://dx.doi.org/10.1016/j.ijrobp.2022.07.1553.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

van Rossum, P., P. Damen, T. Xu, et al. "PD-0152 Radiation-induced lymphopenia risk model predicts durvalumab benefit in non-small cell lung cancer." Radiotherapy and Oncology 182 (May 2023): S113—S114. http://dx.doi.org/10.1016/s0167-8140(23)08796-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Appel, S., J. Bar, Y. R. Lawrence, et al. "PD-0153 Radiation induced lymphopenia, its effect on pathologic regression and prognosis in LA lung cancer." Radiotherapy and Oncology 182 (May 2023): S114—S115. http://dx.doi.org/10.1016/s0167-8140(23)08797-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Orazem, Miha, Vaneja Velenik, and Alojz Ihan. "Sequencing of chemotherapy in total neoadjuvant treatment for rectal cancer does not predict radiation-induced lymphopenia." Radiology and Oncology 59, no. 2 (2025): 252–56. https://doi.org/10.2478/raon-2025-0034.

Full text

Abstract:

Abstract Background Radiation-induced lymphopenia (RIL) is associated with an increased risk of death in solid tumors, including rectal cancer. The aim of this study was to determine whether the sequencing of chemotherapy in total neoadjuvant treatment (TNT) for rectal cancer predicts the development of RIL. Patients and methods We analyzed acute hematologic toxicity data from 53 patients who underwent TNT for locally or locoregionally advanced rectal cancer between July 2022 and April 2023. Twenty-eight patients received induction chemotherapy with capecitabine and oxaliplatin [CAPOX], and 25

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!